adenine and panobinostat

adenine has been researched along with panobinostat in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baselga, J; Brea, EJ; Chang, AY; De Stanchina, E; Fennell, M; Garippa, R; Mondello, P; Scheinberg, DA; Seshan, V; Toska, E; Wendel, HG; Younes, A	1

Other Studies

1 other study(ies) available for adenine and panobinostat

Article	Year
Panobinostat acts synergistically with ibrutinib in diffuse large B cell lymphoma cells with MyD88 L265P mutations. JCI insight, 2017, 03-23, Volume: 2, Issue:6 Topics: Adenine; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Drug Synergism; Histone Deacetylase Inhibitors; Humans; Lymphoma, Large B-Cell, Diffuse; Mice; Mutation; Myeloid Differentiation Factor 88; Panobinostat; Piperidines; Promoter Regions, Genetic; Pyrazoles; Pyrimidines; STAT3 Transcription Factor; Transcription, Genetic; Xenograft Model Antitumor Assays	2017

Article

Year

Panobinostat acts synergistically with ibrutinib in diffuse large B cell lymphoma cells with MyD88 L265P mutations.

JCI insight, 2017, 03-23, Volume: 2, Issue:6

Topics: Adenine; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Drug Synergism; Histone Deacetylase Inhibitors; Humans; Lymphoma, Large B-Cell, Diffuse; Mice; Mutation; Myeloid Differentiation Factor 88; Panobinostat; Piperidines; Promoter Regions, Genetic; Pyrazoles; Pyrimidines; STAT3 Transcription Factor; Transcription, Genetic; Xenograft Model Antitumor Assays

2017